Home > Annual Financials > CIPLA

CIPLA Financial Statement Analysis
[BOM: 500087|NSE : CIPLA]

The Revenues of CIPLA have increased by 13.59% YoY .
The Earnings Per Share (EPS) of CIPLA has increased by 11.29 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

CIPLA Last 5 Annual Financial Results
[BOM: 500087|NSE : CIPLA]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹21,763 Cr₹19,160 Cr₹17,132 Cr₹16,362 Cr₹15,156 Cr
Expenses ₹17,251 Cr₹14,911 Cr₹13,951 Cr₹13,265 Cr₹12,329 Cr
Operating Profit (Excl OI) ₹4,512 Cr₹4,249 Cr₹3,181 Cr₹3,097 Cr₹2,826 Cr
Other Income ₹322 Cr₹270 Cr₹369 Cr₹477 Cr₹358 Cr
Interest ₹106 Cr₹161 Cr₹197 Cr₹168 Cr₹114 Cr
Depreciation ₹1,052 Cr₹1,068 Cr₹1,175 Cr₹1,326 Cr₹1,323 Cr
Profit Before Tax ₹3,493 Cr₹3,290 Cr₹2,178 Cr₹2,079 Cr₹1,669 Cr
Profit After Tax ₹2,559 Cr₹2,401 Cr₹1,547 Cr₹1,510 Cr₹1,419 Cr
Consolidated Net Profit ₹2,517 Cr₹2,405 Cr₹1,547 Cr₹1,528 Cr₹1,411 Cr
Earnings Per Share (Rs)₹34.71₹31.19₹29.82₹19.18₹18.96
PAT Margin (%)9.178.618.515.706.31
ROE(%)12.8513.1014.1310.0910.37
ROCE(%)18.1917.2417.8512.5311.94
Total Debt/Equity(x)0.020.040.100.180.29

Key Financials

Market Cap : ₹ 120,088.6 Cr
Revenue (TTM) : ₹ 25,350.2 Cr
Net Profit(TTM) : ₹ 3,744.0 Cr
EPS (TTM) : ₹ 46.4
P/E (TTM) : 32.1

Industry Peers & Returns1W1M1Y
CIPLA 1.5% 3.3% 70.6%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 4% 61.6%
DIVIS LABORATORIES -2.1% -6% 26.4%
DR REDDYS LABORATORIES 0.7% 0.4% 44.6%
TORRENT PHARMACEUTICALS -4% -2.8% 70.3%
ABBOTT INDIA 6% -3% 39.7%
ZYDUS LIFESCIENCES 0.3% 11.1% 109.1%
ALKEM LABORATORIES -1.5% -8.6% 63.1%
LUPIN -2% -0.5% 149.9%


CIPLA Revenues
[BOM: 500087|NSE : CIPLA]

Y-o-Y

13.59 %

5 Yr CAGR

9.47 %

Years Revenues % Change
Mar2023 ₹21,763 Cr
13.59
Mar2022 ₹19,160 Cr
11.84
Mar2021 ₹17,132 Cr
4.70
Mar2020 ₹16,362 Cr
7.96
Mar2019 ₹15,156 Cr -


CIPLA Operating Profit
[BOM: 500087|NSE : CIPLA]

Y-o-Y

6.20 %

5 Yr CAGR

12.40 %

Years Operating Profit % Change
Mar2023 ₹4,512 Cr
6.20
Mar2022 ₹4,249 Cr
33.57
Mar2021 ₹3,181 Cr
2.70
Mar2020 ₹3,097 Cr
9.59
Mar2019 ₹2,826 Cr -

Operating Margins
Y-o-Y

-6.54 %

5 Yr CAGR

2.68 %

Years Operating Margin% % Change
Mar2023 20.73%
-6.54
Mar2022 22.18%
19.44
Mar2021 18.57%
-1.90
Mar2020 18.93%
1.50
Mar2019 18.65% -

CIPLA Profit After Tax
[BOM: 500087|NSE : CIPLA]

Y-o-Y

4.65 %

5 Yr CAGR

15.58 %

Years Profit After Tax % Change
Mar2023 ₹2,517 Cr
4.65
Mar2022 ₹2,405 Cr
55.50
Mar2021 ₹1,547 Cr
1.23
Mar2020 ₹1,528 Cr
8.31
Mar2019 ₹1,411 Cr -

PAT Margins
Y-o-Y

6.50 %

5 Yr CAGR

9.80 %

Years PAT Margin(%) % Change
Mar2023 9.17 %
6.50
Mar2022 8.61 %
1.18
Mar2021 8.51 %
49.30
Mar2020 5.7 %
-9.67
Mar2019 6.31 % -

CIPLA Earnings Per Share (EPS)
[BOM: 500087|NSE : CIPLA]

Y-o-Y

11.29 %

5 Yr CAGR

16.32 %

Years EPS % Change
Mar2023 ₹35
11.29
Mar2022 ₹31
4.59
Mar2021 ₹30
55.47
Mar2020 ₹19
1.16
Mar2019 ₹19 -

CIPLA Return on Capital Employed (ROCE)
[BOM: 500087|NSE : CIPLA]

Y-o-Y

5.51 %

5 Yr CAGR

11.10 %

Years ROCE % Change
Mar2023 18.19%
5.51
Mar2022 17.24%
-3.42
Mar2021 17.85%
42.46
Mar2020 12.53%
4.94
Mar2019 11.94% -

CIPLA Share Price vs Sensex

Current Share Price : ₹1,487.4
Current MarketCap: ₹ 120,088.6 Cr
Updated EOD on :Mar 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

1.5%

3.3%

70.6%

SENSEX

-1%

1%

24.9%

CIPLA related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX50 -1.3% 0.6% 28.2%
S&P BSE 100 ESG INDEX -1.4% 0% 25.6%
S&P BSE LARGECAP -1.5% 0.6% 31.1%
S&P BSE CARBONEX -1.5% 0.3% 31.2%
S&P BSE 100 LARGECAP TMC -1.6% 0.5% 32.4%
NSE Indices1W1M1Y
NIFTY GROWTH SECTOR 15 1.2% 11.6% 9.1%
NIFTY QUALITY LOW-VOLATILTY 30 -0.8% 0.6% 34.7%
NIFTY 50 -1.2% 0.7% 28.6%
NIFTY100 LOW VOLATILITY 30 -1.5% 0.3% 39.6%
NIFTY 100 -1.6% 0.6% 32.6%

You may also like the below Video Courses


FAQ about CIPLA Financials


How the annual revenues of CIPLA have changed ?

The Revenues of CIPLA have increased by 13.59% YoY .

How the Earnings per Share (EPS) of CIPLA have changed?

The Earnings Per Share (EPS) of CIPLA has increased by 11.29 % YoY .